Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Indiana University
Study ID
NCT05611307
Status
Recruiting
Apply to this trial

Conditions

  • ASCVD
  • Bone Marrow Transplant Complications
  • Cisplatin Adverse Reaction
  • Coronary Artery Disease
  • Hypogonadism, Male
  • Lipid Disorder
  • Survivorship
  • Testicular Cancer

Eligibility Criteria

Sex
MALE
Age
18 Years - 99 Years
Healthy Volunteers
Not accepted

Interventions

  • Lipid profile — DIAGNOSTIC_TEST
    Advanced lipid profile
  • Coronary artery assessment — DIAGNOSTIC_TEST
    Coronary artery assessment via CT scans
  • Hormone levels for hypogonadism — DIAGNOSTIC_TEST
    Hormone levels for hypogonadism

Study Details

Late subclinical cardiovascular disease in testicular cancer survivors exposed to cisplatin-based chemotherapy and bone marrow transplant

Key Dates

First listed
Nov 10, 2022
Start date
Oct 11, 2022
Status verified
Jul 2026
Primary completion
Dec 31, 2026
Completion
Aug 31, 2027

Study Design

Enrollment
150 participants (estimated)

Arms

  • Arm: Surgical/Surveillance
    TCS cured with surgical resection and surveillance (surgical/surveillance, Arm 1)
  • Arm: Cisplatin-based chemotherapy (CBCT)
    TCS treat with one or more lines of cisplatin-based chemotherapy
  • Arm: Cisplatin-based chemotherapy and Bone Marrow Transplant (CBCT/BMT)
    TCS treat with one or more lines of cisplatin-based chemotherapy, and who have undergone bone marrow transplant

Primary Outcome Measure

Lipid profile [ Time Frame: More than 5 years after testicular cancer diagnosis, At recruitment ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Indiana UniversityIndianapolisIndiana46202
Elizabeth Rowe
[email protected]
(317) 278-1185

Find similar trials in Indianapolis, IN

By research site
Indiana University· Indianapolis, IN

Related Studies